Peter M. Glazer, MD, PhD (IMAGE)
Caption
Dr. Peter Glazer led new research showing advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.
Credit
Yale Cancer Center
Usage Restrictions
None
License
Licensed content